Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Hyaluronidase for Local Blocks in Eyelid Surgery
NCT02059694Withdrawn
- Sponsor
- Duke University
- Primary completion
- Jul 2015
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Randomised trial of hyaluronidase (2 arms), sponsored by Duke University. Primary endpoint: Pain sensation at 5 minutes. Status: withdrawn.
02
Drugs
hyaluronidase
Beyond the preview
Go deeper on NCT02059694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02059694.